US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Tracks Biotherapeutics Inc

31.85

-0.1600-0.50%

Post-market: 31.850.00000.00%16:38 EDT

Volume:855.24K

Turnover:27.21M

Market Cap:1.14B

PE:-7.03

High:33.28

Open:31.96

Low:30.71

Close:32.01

52wk High:49.91

52wk Low:14.72

Shares:35.73M

Float Shares:34.75M

Volume Ratio:1.00

T/O Rate:2.46%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.5296

ROE:-48.91%

ROA:-28.97%

PB:6.74

PE(LYR):- -

Loading ...

Overview Company News Filings

First Tracks Q2 FY26 Net Loss Narrows to $33.37 Million

Press Release: First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

First Tracks Biotherap Price Target Raised to $65.00/Share from $45.00 by UBS

UBS Adjusts First Tracks Biotherapeutics PT to $65 From $45, Maintains Buy Rating

MT Newswires Live

First Tracks Biotherapeutics Inc : UBS Raises Target Price to $65 from $45

THOMSON REUTERS

First Tracks Biotherapeutics Inc. : Wells Fargo Raises Target Price to $55 from $30

THOMSON REUTERS

First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from Wells Fargo

Top Premarket Gainers

MT Newswires Live

First Tracks is Maintained at Overweight by Barclays

First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from UBS

J.P. Morgan Remains a Buy on First Tracks Biotherapeutics Inc (TRAX)

First Tracks is Maintained at Buy by HC Wainwright & Co.

First Tracks Biotherapeutics, Inc. : H.c. Wainwright Raises Target Price to $44 from $30

THOMSON REUTERS

Wells Fargo Reaffirms Their Buy Rating on First Tracks Biotherapeutics Inc (TRAX)

Analysts Offer Insights on NA Companies: Fervo Energy Company Class A (FRVO) and First Tracks Biotherapeutics Inc (TRAX)

First Tracks Price Target Maintained with a $30.00/share by HC Wainwright & Co.

Buy Rating on First Tracks (TRAX) Driven by Strengthening IL-15/CD122 Pathway Validation and Upcoming ANB033 Clinical Catalysts in Celiac Disease and Vitiligo

First Tracks Biotherapeutics Shares Edge Up on Sublease Deal

First Tracks Biotherapeutics subleases 45,057 sq ft San Diego space from AnaptysBio

First Tracks Biotherapeutics Inc. : Wells Fargo Initiates Coverage With Overweight Rating and Target Price $30

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/TRAX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","market":"US","secType":"STK","nameCN":"First Tracks Biotherapeutics Inc","latestPrice":31.85,"timestamp":1791576000000,"preClose":32.01,"halted":0,"volume":855239,"hourTrading":{"tag":"盘后","latestPrice":31.85,"preClose":31.85,"latestTime":"16:38 EDT","volume":4442,"amount":141477.7,"timestamp":1791578282930,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.004998437988128604,"floatShares":34748800,"shares":35730843,"eps":-4.529554,"marketStatus":"Post-Mkt","change":-0.16,"latestTime":"10-09 18:56:22 EDT","open":31.96,"high":33.28,"low":30.71,"amount":27209856.4045,"amplitude":0.080287,"askPrice":32.47,"askSize":61,"bidPrice":31.85,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-4.529554,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":32.01,"preHourTrading":{"tag":"盘前","latestPrice":31.5,"preClose":32.01,"latestTime":"09:28 EDT","volume":11,"amount":344.999996,"timestamp":1791552528037,"change":-0.51,"changeRate":-0.015933,"amplitude":0.03124},"postHourTrading":{"tag":"盘后","latestPrice":31.85,"preClose":31.85,"latestTime":"16:38 EDT","volume":4442,"amount":141477.7,"timestamp":1791578282930,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.997066,"impliedVol":1.0418,"impliedVolPercentile":0.7453},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","floatShares":34748800,"roa":"-28.97%","roe":"-48.91%","lyrEps":0,"volumeRatio":0.997066,"shares":35730843,"dividePrice":0,"high":33.28,"amplitude":0.080287,"preClose":32.01,"low":30.71,"week52Low":14.72,"pbRate":"6.74","week52High":49.9114,"institutionHeld":0,"latestPrice":31.85,"committee":-0.418605,"eps":-4.529554,"divideRate":0,"volume":855239,"delay":0,"ttmEps":-4.529554,"open":31.96,"prevYearClose":20,"prevWeekClose":33.28,"prevMonthClose":35.44,"prevQuarterClose":35.44,"fiveDayClose":33.28,"twentyDayClose":36.44,"sixtyDayClose":36.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRAX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"TRAX","fiscalQuarterEnding":"2026/06","expectedEps":-0.74,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":12,"updateTime":1790827200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRAX","date":"2026-10-08","current":-7.031597,"percent":0.535088,"low":-10.141689,"twenty":-9.326788,"median":-7.353282,"eighty":-3.657031,"high":-3.156022,"avg":-6.452393,"sd":2.571461,"marketCap":1093006487},"quantilePoints":[{"date":"2026-04-24","current":-3.975194,"twenty":-3.975194,"median":-3.975194,"eighty":-3.975194,"marketCap":660227979},{"date":"2026-05-01","current":-4.868566,"twenty":-4.868566,"median":-4.085034,"eighty":-3.799448,"marketCap":808605530},{"date":"2026-05-08","current":-3.728313,"twenty":-4.68236,"median":-4.236719,"eighty":-3.799448,"marketCap":619224346},{"date":"2026-05-15","current":-3.799448,"twenty":-4.433387,"median":-4.031683,"eighty":-3.799448,"marketCap":631038952},{"date":"2026-05-22","current":-3.452672,"twenty":-4.299486,"median":-3.855938,"eighty":-3.664859,"marketCap":584796305},{"date":"2026-05-29","current":-3.259026,"twenty":-4.249272,"median":-3.799448,"eighty":-3.475745,"marketCap":551997467},{"date":"2026-06-05","current":-3.749322,"twenty":-4.203244,"median":-3.738817,"eighty":-3.411676,"marketCap":635041334},{"date":"2026-06-12","current":-3.508294,"twenty":-4.109513,"median":-3.726221,"eighty":-3.329068,"marketCap":594217248},{"date":"2026-06-18","current":-3.743141,"twenty":-4.020386,"median":-3.683399,"eighty":-3.361617,"marketCap":633994562},{"date":"2026-06-26","current":-3.372329,"twenty":-3.945066,"median":-3.663829,"eighty":-3.37851,"marketCap":571188276},{"date":"2026-07-02","current":-3.829664,"twenty":-3.955109,"median":-3.663829,"eighty":-3.376449,"marketCap":648649362},{"date":"2026-07-10","current":-6.674616,"twenty":-4.112294,"median":-3.726221,"eighty":-3.397462,"marketCap":1130513144},{"date":"2026-07-17","current":-7.459502,"twenty":-4.261943,"median":-3.735727,"eighty":-3.424655,"marketCap":1263453116},{"date":"2026-07-24","current":-7.754091,"twenty":-4.794084,"median":-3.774042,"eighty":-3.434543,"marketCap":1313349220},{"date":"2026-07-31","current":-9.842999,"twenty":-6.999282,"median":-3.799448,"eighty":-3.441135,"marketCap":1667157964},{"date":"2026-08-07","current":-9.334163,"twenty":-7.464446,"median":-3.842801,"eighty":-3.45844,"marketCap":1580973783},{"date":"2026-08-14","current":-9.814035,"twenty":-7.742967,"median":-3.975194,"eighty":-3.486045,"marketCap":1573229017},{"date":"2026-08-21","current":-9.33927,"twenty":-8.651869,"median":-4.081492,"eighty":-3.504998,"marketCap":1497122321},{"date":"2026-08-28","current":-9.97229,"twenty":-9.339073,"median":-4.144854,"eighty":-3.509324,"marketCap":1598597915},{"date":"2026-09-04","current":-9.475235,"twenty":-9.448042,"median":-4.257739,"eighty":-3.516946,"marketCap":1518918135},{"date":"2026-09-11","current":-8.465524,"twenty":-9.33927,"median":-4.366436,"eighty":-3.530954,"marketCap":1357057417},{"date":"2026-09-18","current":-8.737455,"twenty":-9.338283,"median":-4.868566,"eighty":-3.539195,"marketCap":1400649045},{"date":"2026-09-25","current":-7.986302,"twenty":-9.334163,"median":-6.877533,"eighty":-3.588636,"marketCap":1280236104},{"date":"2026-10-02","current":-7.560574,"twenty":-9.330354,"median":-7.443021,"eighty":-3.633958,"marketCap":1211990194},{"date":"2026-10-08","current":-6.818336,"twenty":-9.326788,"median":-7.353282,"eighty":-3.657031,"marketCap":1093006487}],"updateTime":1791586582242},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRAX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659918900","title":"First Tracks Q2 FY26 Net Loss Narrows to $33.37 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659918900","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659918900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:18","pubTimestamp":1786565937,"startTime":"0","endTime":"0","summary":"First Tracks Q2 FY26 net loss narrows to $33.37 millionFirst Tracks posted a Q2 net loss of $33.4 million, narrowing 21.36% from a $42.4 million loss a year earlier.Loss per share improved to $0.95 fr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL7xKFl0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","BK4585","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","BK4112","BK4139","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","TRAX","LU2210149790.SGD","SG9999014013.SGD","BK4588","LU0314104364.USD","BCDF","SG9999014005.SGD","IE00BN0W2V16.EUR","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659009089","title":"Press Release: First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659009089","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659009089?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:15","pubTimestamp":1786565700,"startTime":"0","endTime":"0","summary":"-- Completed enrollment for Cohort 1  of Phase 1b ANB033. trial in celiac disease ; top-line Cohort 1 data reaffirmed for Q4. -- Cohort 2  enhanced to enroll up to 40 patients including. those with a broad range of histologic  and symptom. severity to further inform future development; top-line Cohort 2 data. -- U.S. FDA granted Fast Track designation for ANB033 for the treatment of. -- Enrollment ongoing for Phase 1b ANB033 trial in eosinophilic esophagitis. -- Reiterating cash-runway into Q2 2028, including the expansion of ANB033. -- U.S. FDA granted Fast Track designation to ANB033 for the. treatment of people with CeD on a gluten-free diet. -- 70-patient trial assessing one dose level of subcutaneously. -- Cohort 1  is a gluten-challenge study to assess the. -- Cohort 2  assesses the possibility of mucosal healing","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4077","TRAX","RA","BK4139","SLE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951302","title":"First Tracks Biotherap Price Target Raised to $65.00/Share from $45.00 by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951302?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:26","pubTimestamp":1786393560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658317769","title":"UBS Adjusts First Tracks Biotherapeutics PT to $65 From $45, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658317769","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658317769?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:29","pubTimestamp":1786368555,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics (TRAX) has an average rating of Buy and mean price target of $53.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931559","title":"First Tracks Biotherapeutics Inc : UBS Raises Target Price to $65 from $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931559","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931559?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:10","pubTimestamp":1786367459,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nAZN4TD0K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654300379","title":"First Tracks Biotherapeutics Inc. : Wells Fargo Raises Target Price to $55 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2654300379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654300379?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:26","pubTimestamp":1785234413,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nAZN4TAB3Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654071064","title":"First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2654071064","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654071064?lang=en_us&edition=fundamental","pubTime":"2026-07-28 15:35","pubTimestamp":1785224115,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Derek Archila from Wells Fargo maintained a Buy rating on First Tracks Biotherapeutics Inc, with a price target of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-gets-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-gets-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0208291251.USD","TFNS","BK4207","LU0648001328.SGD","LU1201861249.SGD","LU0211327993.USD","LU0314106906.USD","TRAX","IYF","LU0211328371.USD","LU0251131958.USD","LU0310799852.SGD","LU0052756011.USD","LU0048573561.USD","LU1267930490.SGD","LU0130517989.USD","LU2236285917.USD","LU0128525689.USD","LU0154236417.USD","LU1035773651.USD","KBWB","LU1814569148.SGD","LU1363072403.SGD","LU0251142724.SGD","LU0149725797.USD","LU0289960550.SGD","LU0980610538.SGD","LU0320765489.SGD","LU0640476718.USD","LU1074936037.SGD","LU0070302665.USD","LU0708994859.HKD","FTXO","IE00B19Z3B42.SGD","IE0002270589.USD","LU0029864427.USD","LU0942090050.USD","LU1280957306.USD","LU0477156953.USD","LU1267930573.SGD","LU0130102774.USD","LU0267386448.USD","LU0162691827.USD","BK4588","PGF","LU0106831901.USD","LU0072461881.USD","LU0175139822.USD","LU0787776722.HKD","LU0971096721.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654540014","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2654540014","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654540014?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:04","pubTimestamp":1785150251,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics  shares were up 41% in Monday premarket activity, recovering from a 5.6% loss in the previous session.Baiya International Group  stock was 38% higher, rebounding from a 28% decline in the earlier session.Forte Biosciences  shares were up 39% after Argenx agreed to acquire the company for $77 per share in cash.T3 Defense  stock was 42% higher, adding to an 11.5% gain in the previous session.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","FBRX","BK4139","DFNS","BIYA","TRAX","BK4130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653208461","title":"First Tracks is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2653208461","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653208461?lang=en_us&edition=fundamental","pubTime":"2026-07-21 21:24","pubTimestamp":1784640240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings(END) Dow Jones NewswiresJuly 21, 2026 09:24 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650138272","title":"First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2650138272","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650138272?lang=en_us&edition=fundamental","pubTime":"2026-07-10 21:15","pubTimestamp":1783689330,"startTime":"0","endTime":"0","summary":"In a report released today, from UBS maintained a Buy rating on First Tracks Biotherapeutics Inc, with a price target of $45.00. Currently, the ana...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-gets-a-buy-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-gets-a-buy-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650821311","title":"J.P. Morgan Remains a Buy on First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650821311","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650821311?lang=en_us&edition=fundamental","pubTime":"2026-07-10 19:15","pubTimestamp":1783682114,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Anupam Rama from J.P. Morgan reiterated a Buy rating on First Tracks Biotherapeutics Inc, with a price target of $3...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2264538146.SGD","LU0267386448.USD","BK4585","LU1732800096.USD","TRAX","LU1720051108.HKD","LU0795875169.SGD","LU0912757837.SGD","BK4139","LU0528227936.USD","LU1074936037.SGD","LU1548497426.USD","LU0557290698.USD","LU0106831901.USD","LU1720051017.SGD","BK4588","KBWB","LU0158827948.USD","BK4581","LU2487616109.SGD","LU2028103732.USD","LU0006306889.USD","IE00BKVL7J92.USD","LU0390134368.USD","LU1363072403.SGD","IE00BZ1G4Q59.USD","LU2023251221.USD","LU0210528500.USD","LU2271345857.HKD","LU0158827781.USD","LU1244550577.SGD","LU2133065610.SGD","BK4127","LU0106261372.USD","LU1244550494.USD","LU2111349929.HKD","LU1989772923.USD","BK4504","LU0098860793.USD","LU0882574139.USD","LU2089284900.SGD","LU0795875086.SGD","LU2357305700.SGD","LU0053666078.USD","LU2089283258.USD","LU0234570918.USD","BK4516","IAI","BK4534","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650812001","title":"First Tracks is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2650812001","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650812001?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:23","pubTimestamp":1783678980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings(END) Dow Jones NewswiresJuly 10, 2026 06:23 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650818901","title":"First Tracks Biotherapeutics, Inc. : H.c. Wainwright Raises Target Price to $44 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2650818901","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650818901?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:04","pubTimestamp":1783677894,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nAZN4T73S4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650189030","title":"Wells Fargo Reaffirms Their Buy Rating on First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650189030","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650189030?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:55","pubTimestamp":1783677344,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Derek Archila from Wells Fargo maintained a Buy rating on First Tracks Biotherapeutics Inc, with a price target of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-reaffirms-their-buy-rating-on-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-reaffirms-their-buy-rating-on-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650824183","title":"Analysts Offer Insights on NA Companies: Fervo Energy Company Class A (FRVO) and First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650824183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650824183?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:11","pubTimestamp":1783671076,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Fervo Energy Company Class A (FRVO) and First Tracks Biother...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-fervo-energy-company-class-a-frvo-and-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-fervo-energy-company-class-a-frvo-and-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TRAX","BK4133","FRVO","BK4141","NA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649991865","title":"First Tracks Price Target Maintained with a $30.00/share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2649991865","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649991865?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:48","pubTimestamp":1783518480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings(END) Dow Jones NewswiresJuly 08, 2026 09:48 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649999736","title":"Buy Rating on First Tracks (TRAX) Driven by Strengthening IL-15/CD122 Pathway Validation and Upcoming ANB033 Clinical Catalysts in Celiac Disease and Vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=2649999736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649999736?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:25","pubTimestamp":1783517125,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Emily Bodnar from H.C. Wainwright maintained a Buy rating on First Tracks Biotherapeutics Inc, with a price target ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-first-tracks-trax-driven-by-strengthening-il-15-cd122-pathway-validation-and-upcoming-anb033-clinical-catalysts-in-celiac-disease-and-vitiligo-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-first-tracks-trax-driven-by-strengthening-il-15-cd122-pathway-validation-and-upcoming-anb033-clinical-catalysts-in-celiac-disease-and-vitiligo-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645008169","title":"First Tracks Biotherapeutics Shares Edge Up on Sublease Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2645008169","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645008169?lang=en_us&edition=fundamental","pubTime":"2026-06-23 05:27","pubTimestamp":1782163620,"startTime":"0","endTime":"0","summary":"Shares of First Tracks Biotherapeutics gained after the company disclosed it is subleasing office space from AnaptysBio.The stock rose 3.7% to $19 in after-hours trading on Monday. At market close, shares were up 6.6% in the past month.Under the agreement, AnaptysBio will sublease to First Tracks about 45,057 square feet of space in San Diego, Calif., First Tracks disclosed in a filing with the Securities and Exchange Commission.The sublease commenced on June 15 and has a term of 12 months, with the option to extend for a renewal period that would continue until April 4, 2028, or twelve months from the commencement of the renewal term, whichever is earlier.In April, First Tracks completed a spin-out from AnaptysBio.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645307748","title":"First Tracks Biotherapeutics subleases 45,057 sq ft San Diego space from AnaptysBio","url":"https://stock-news.laohu8.com/highlight/detail?id=2645307748","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645307748?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:06","pubTimestamp":1782158772,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics entered a 12-month sublease for about 45,057 rentable square feet at 10770 Wateridge Circle in San Diego.The sublease started June 15, 2026; it can be renewed to as late as April 4, 2028, subject to notice requirements.Monthly rent is set to match the master lease basic rent and additional rent; First Tracks also covers certain service charges it requests.The company can terminate at any time with at least three months’ prior written notice.The sublease ends automatically if AnaptysBio’s master lease rights terminate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. First Tracks Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDLj39vP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX","ANAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641485039","title":"First Tracks Biotherapeutics Inc. : Wells Fargo Initiates Coverage With Overweight Rating and Target Price $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2641485039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641485039?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:44","pubTimestamp":1780915461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nAZN4T15QU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":66,"code":"91000000","status":"200"}]}}